Targeted drug-loaded microspheres based on natural collagen as well as preparation method and application of targeted drug-loaded microspheres
Through targeted drug-loading microspheres based on natural collagen, combined with breast cancer cell receptors, and releasing doxorubicin, the complications of existing breast cancer treatment methods and the problem of insufficient stability of targeted drug-loading microspheres is solved, and the patient can achieve Efficient and accurate breast cancer treatment effects.
Patent Information
- Application Number
- CN202411101409.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-26
AI Technical Summary
Existing breast cancer treatment methods such as surgery, radiotherapy and chemotherapy have complications, nonselective killing effects and side effects. Targeted drug-loading microspheres such as antibodies, nucleic acid aptamers and polypeptides targeting drug-loading are stable and specific in vivo. Inadequate, it is difficult to achieve efficient and precise treatment.
Using targeted drug-loading microspheres based on natural collagen, through the binding of polycaprolactone microspheres and natural collagen, the specific identification of breast cancer cell receptors is used to release doxorubicin to inhibit tumor growth and spread. , the preparation method includes steps such as emulsification, stirring, centrifugation, washing, and freeze-drying.
Targeted drug-loading microspheres with strong stability and excellent biocompatibility can specifically identify and kill breast cancer cells, reduce side effects, and improve treatment effect.
Smart Images

Figure CN119015437A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomaterials, and more specifically, relates to a targeted drug-loaded microsphere based on natural collagen, a preparation method and an application thereof. Background Art
[0002] Breast cancer is the most common and most lethal malignant tumor in women, which seriously threatens women's physical and mental health. Achieving efficient treatment of breast cancer has always been a difficult problem that scientists have been working hard to overcome. Currently, surgery, radiotherapy, and chemotherapy are the main means of treating breast cancer. Surgical treatment can completely remove the tumor and improve the cure rate, but it is prone to complications. Radiotherapy can effectively improve the local cure rate and prevent recurrence, but it is a radiotherapy method and may cause secondary damage to patients. Chemotherapy can kill subclinical lesions and prevent recurrence and metastasis, but it is a non-selective killing effect and also damages normal cells and organ tissues.
[0003] In recent years, in order to overcome the problems caused by radiotherapy and chemotherapy in the treatment of breast cancer, targeted drug-loaded microspheres based on biological molecules such as antibodies, nucleic acid aptamers, and targeted peptides have become new weapons for the treatment of breast cancer due to their high precision, small side effects, and significant efficacy. Drug-loaded microspheres with antibodies as targeted recognition materials have strong specificity and affinity, but the antibody preparation process is cumbersome, the cost is high, and there may be immune reactions. Targeted drug-loaded microspheres with nucleic acid aptamers for breast cancer recognition have strong specificity, but nucleic acid aptamers have poor stability in the body and are easily degraded. Targeted drug-loaded microspheres with peptides as recognition molecules have strong affinity, but most peptides are quickly cleared by the kidneys in the body and have insufficient stability in the body.
[0004] Collagen is one of the main components of the extracellular matrix. Its unique triple helix structure gives it excellent biocompatibility, low immunogenicity and biological stability. At the same time, collagen has the ability to specifically recognize breast cancer cell receptors (integrin, DDR, etc.) that are highly expressed, which provides a guarantee for the construction of targeted drug-loaded microspheres with superior performance. Summary of the invention
[0005] The purpose of the present invention is to address the deficiencies of the prior art and to propose a natural collagen-based targeted drug-loaded microsphere and its preparation method and application. The present invention prepares a natural collagen-based drug-loaded microsphere with strong stability, excellent biocompatibility, and targeted treatment of breast cancer.
[0006] In order to achieve the above object, the first aspect of the present invention provides a method for preparing targeted drug-loaded microspheres based on natural collagen, the preparation method comprising the following steps:
[0007] S1: uniformly mixing polycaprolactone and a solvent to obtain an oil phase solution; uniformly mixing water and an emulsifier to obtain an aqueous phase solution;
[0008] S2: mixing the aqueous phase solution and the oil phase solution and performing shear emulsification to obtain an oil-in-water emulsion;
[0009] S3: stirring, centrifuging, discarding the supernatant, washing and freeze-drying the oil-in-water emulsion in sequence to obtain polycaprolactone microspheres;
[0010] S4: uniformly mixing water and doxorubicin hydrochloride to obtain a doxorubicin solution;
[0011] S5: mixing the polycaprolactone microspheres and the doxorubicin solution and sequentially stirring, centrifuging, discarding the supernatant, washing and freeze-drying to obtain drug-loaded polycaprolactone microspheres;
[0012] S6: Under low temperature conditions, the acetic acid aqueous solution and the natural collagen are uniformly mixed and dialyzed with pure water to obtain a collagen solution;
[0013] S7: Soaking the drug-loaded polycaprolactone microspheres in the collagen solution, and then sequentially centrifuging, discarding the supernatant and freeze-drying to obtain the targeted drug-loaded microspheres based on natural collagen.
[0014] According to the present invention, preferably, in step S1:
[0015] The concentration of polycaprolactone in the oil phase solution is 5-30 mg / mL;
[0016] The solvent is at least one of dichloromethane, chloroform and N,N-dimethylformamide;
[0017] The concentration of the emulsifier in the aqueous phase solution is 1-7 mg / mL;
[0018] The emulsifier is at least one of polyvinyl alcohol, carboxymethyl cellulose and chitosan.
[0019] According to the present invention, preferably, in step S2:
[0020] The volume ratio of the aqueous phase solution to the oil phase solution is 3:1-9:1;
[0021] The shearing speed is 5000-15000 rpm, and the shearing time is 3-12 min.
[0022] According to the present invention, preferably, in step S3:
[0023] The stirring rate is 300-800 rpm, and the time is 12-36 hours. In the present invention, the solvent is volatilized by stirring in step S3;
[0024] The centrifugal speed is 8000-12000rpm and the time is 10-30min;
[0025] The freeze-drying time is 24-48h.
[0026] According to the present invention, preferably, in step S4: the concentration of the doxorubicin solution is 2-6 mg / mL.
[0027] According to the present invention, preferably, in step S5:
[0028] The dosage ratio of the polycaprolactone microspheres to the doxorubicin solution is 10:1-30:1 mg / mL;
[0029] The stirring rate is 200-500 rpm and the time is 24-48 hours;
[0030] The centrifugal speed is 8000-12000rpm and the time is 5-20min;
[0031] The freeze-drying time is 24-48h.
[0032] According to the present invention, preferably, in step S6:
[0033] The natural collagen is natural type I collagen with a complete triple helical molecular structure that is extracted, separated and purified from the skin and Achilles tendon tissues of mammals, fish and amphibians;
[0034] The low temperature condition is a temperature less than 15°C (too high a temperature will cause collagen denaturation);
[0035] The concentration of the acetic acid aqueous solution is 0.1-0.5 mol / L;
[0036] The concentration of the collagen solution is 0.05-0.2 mg / mL.
[0037] According to the present invention, preferably, in step S7:
[0038] The soaking time is 6-10h;
[0039] The centrifugal speed is 8000-12000rpm and the time is 5-15min;
[0040] The freeze-drying time is 24-48h.
[0041] The second aspect of the present invention provides targeted drug-loaded microspheres based on natural collagen prepared by the method for preparing targeted drug-loaded microspheres based on natural collagen.
[0042] The third aspect of the present invention provides the use of the natural collagen-based targeted drug-loaded microspheres in the preparation of drugs for treating breast cancer.
[0043] The beneficial effects of the technical solution of the present invention are as follows:
[0044] The invention prepares natural collagen-based drug-loaded microspheres which have strong stability, excellent biocompatibility and can target and treat breast cancer.
[0045] Natural collagen can specifically bind to DDR1 cell receptors. At the same time, breast cancer cells have abnormally expressed DDR1 receptors. The targeted drug-loaded microspheres based on natural collagen of the present invention can target and identify breast cancer cells through the collagen on the surface of the microspheres and release doxorubicin, which can inhibit the growth and spread of tumors by killing breast cancer cells, thereby achieving the purpose of treating breast cancer.
[0046] Other features and advantages of the present invention will be described in detail in the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] The above and other objects, features and advantages of the present invention will become more apparent through a more detailed description of exemplary embodiments of the present invention in conjunction with the accompanying drawings, wherein like reference numerals generally represent like components throughout the exemplary embodiments of the present invention.
[0048] Figure 1 The transmission electron microscope image of the targeted drug-loaded microspheres based on natural collagen prepared by the method for preparing targeted drug-loaded microspheres based on natural collagen provided in Example 1 of the present invention is shown.
[0049] Figure 2 The diagram shows a hemolysis test (phosphate buffered saline, PBS) of targeted drug-loaded microspheres based on natural collagen prepared by the method for preparing targeted drug-loaded microspheres based on natural collagen provided in Example 1 of the present invention.
[0050] Figure 3 The stability test graph of targeted drug-loaded microspheres based on natural collagen prepared by the preparation method of targeted drug-loaded microspheres based on natural collagen provided in Example 1 of the present invention is shown ("Particle size" particle size, "Time (day)" time (day), "Zeta potential" Zeta potential).
[0051] Figure 4 The Calcein / PI live and dead cell staining image ("PhaseContrast" phase contrast, "Calcein" calcein, "PI" propidium iodide, "Merged" merge) of targeted drug-loaded microspheres based on natural collagen prepared by the preparation method of targeted drug-loaded microspheres based on natural collagen provided in Example 1 of the present invention is shown. DETAILED DESCRIPTION
[0052] The preferred embodiments of the present invention will be described in more detail below. Although the preferred embodiments of the present invention are described below, it should be understood that the present invention can be implemented in various forms and should not be limited by the embodiments set forth herein. On the contrary, these embodiments are provided to make the present invention more thorough and complete, and to fully convey the scope of the present invention to those skilled in the art.
[0053] Example 1
[0054] This embodiment provides a method for preparing targeted drug-loaded microspheres based on natural collagen, and the preparation method comprises the following steps:
[0055] S1: uniformly mixing polycaprolactone and dichloromethane to obtain an oil phase solution (wherein the concentration of polycaprolactone is 15 mg / mL); uniformly mixing pure water and polyvinyl alcohol to obtain an aqueous phase solution (wherein the concentration of polyvinyl alcohol is 3 mg / mL);
[0056] S2: slowly add the aqueous phase solution into the oil phase solution (the volume ratio of the two is 7:1), and shear emulsify at a speed of 10000 rpm for 8 minutes to obtain an oil-in-water emulsion;
[0057] S3: stirring the oil-in-water emulsion at 500 rpm for 24 h to completely volatilize the dichloromethane, then centrifuging at 10,000 rpm for 15 min, discarding the supernatant, washing the precipitate with pure water three times, and freeze-drying it for 24 h to obtain polycaprolactone microspheres;
[0058] S4: uniformly mixing water and doxorubicin hydrochloride to obtain a 3 mg / mL doxorubicin solution;
[0059] S5: 20 mg of polycaprolactone microspheres and 1 mL of 3 mg / mL doxorubicin solution were mixed, stirred at 300 rpm for 24 h, and then centrifuged at 10,000 rpm for 10 min. The supernatant was discarded, and the precipitate was washed three times with pure water and freeze-dried for 24 h to obtain drug-loaded polycaprolactone microspheres;
[0060] S6: at a temperature below 15° C., uniformly mixing the acetic acid aqueous solution with bovine Achilles tendon collagen (natural type I collagen with a complete triple helical molecular structure) and dialyzing with pure water to obtain a 0.1 mg / mL bovine Achilles tendon collagen solution;
[0061] S7: Soak the drug-loaded polycaprolactone microspheres in the 0.1 mg / mL bovine Achilles tendon collagen solution for 6 hours, then centrifuge at 10,000 rpm for 7 minutes, discard the supernatant, and freeze-dry the precipitate for 36 hours to obtain the targeted drug-loaded microspheres based on natural collagen.
[0062] Example 2
[0063] This embodiment provides a method for preparing targeted drug-loaded microspheres based on natural collagen. The difference between this embodiment and embodiment 1 is only that:
[0064] The concentration of polycaprolactone in the oil phase solution is 20 mg / mL; the concentration of polyvinyl alcohol in the water phase solution is 5 mg / mL;
[0065] Slowly add the aqueous phase solution to the oil phase solution, with the volume ratio of the two being 9:1;
[0066] Step S6, at a temperature below 15° C., uniformly mixing the acetic acid aqueous solution with pigskin collagen (natural type I collagen with a complete triple helical molecular structure) and dialyzing with pure water to obtain a 0.15 mg / mL pigskin collagen solution;
[0067] Step S7, soaking the drug-loaded polycaprolactone microspheres in the 0.15 mg / mL pig skin collagen solution for 8 hours, then centrifuging at 10000 rpm for 8 minutes, discarding the supernatant, and freeze-drying the precipitate for 48 hours to obtain the targeted drug-loaded microspheres based on natural collagen.
[0068] Example 3
[0069] This embodiment provides a method for preparing targeted drug-loaded microspheres based on natural collagen. The difference between this embodiment and embodiment 1 is only that:
[0070] Step S2, slowly adding the aqueous phase solution to the oil phase solution (the volume ratio of the two is 6:1), shearing and emulsifying at a speed of 10000 rpm for 10 minutes to obtain an oil-in-water emulsion;
[0071] Step S4, uniformly mixing water and doxorubicin hydrochloride to obtain a 4 mg / mL doxorubicin solution;
[0072] Step S5, 20 mg of polycaprolactone microspheres and 1 mL of 4 mg / mL doxorubicin solution were mixed, stirred at 300 rpm for 24 h, and then centrifuged at 10,000 rpm for 12 min, the supernatant was discarded, the precipitate was washed three times with pure water, and freeze-dried for 24 h to obtain drug-loaded polycaprolactone microspheres;
[0073] Step S6, at a temperature below 15° C., uniformly mixing the aqueous acetic acid solution with bullfrog skin collagen (natural type I collagen with a complete triple helical molecular structure) and dialyzing with pure water to obtain a 0.2 mg / mL bullfrog skin collagen solution;
[0074] Step S7, soaking the drug-loaded polycaprolactone microspheres in the 0.2 mg / mL bullfrog skin collagen solution for 10 hours, then centrifuging at 10000 rpm for 10 minutes, discarding the supernatant, and freeze-drying the precipitate for 36 hours to obtain the targeted drug-loaded microspheres based on natural collagen.
[0075] like Figure 2 The figure shows the hemolysis test of the targeted drug-loaded microspheres based on natural collagen obtained in Example 1. Figure 2 It can be seen that:
[0076] After adding the microspheres of Example 1, all the red blood cells sank, and the supernatant was colorless and clear, indicating that no hemolysis occurred;
[0077] The positive control group (pure water) can cause complete hemolysis, and the solution is red;
[0078] The negative control group (phosphate buffered saline, PBS) was clear and transparent, and no hemolysis occurred.
[0079] This shows that the microspheres obtained in Example 1 have good biocompatibility.
[0080] like Figure 3 As shown in FIG. 1 , it is a stability test diagram of the targeted drug-loaded microspheres based on natural collagen obtained in Example 1. Figure 3 It can be seen that within the 9-day storage period, the average hydrated particle size of the microspheres obtained in Example 1 in the PBS system is between 600-650 nm, and the Zeta potential is within the range of -14.5 mV-15 mV. The fluctuation range of the particle size and Zeta potential of the microspheres obtained in Example 1 is small, indicating that the microspheres obtained in Example 1 have good stability.
[0081] like Figure 4 As shown in FIG. 1 , the Calcein / PI live and dead cell staining image of the targeted drug-loaded microspheres based on natural collagen obtained in Example 1, in which Calcein stains live cells, showing green fluorescence, and PI stains dead cells, showing red fluorescence. Figure 4 It can be seen that:
[0082] Under green fluorescence, the breast cancer cells (MCF-7 cells) in the control group grew well and had normal cell morphology. Under red fluorescence, almost no red spots were observed, and there were basically no dead cells.
[0083] Many red dots can be observed in the doxorubicin group and the microsphere group under red fluorescence, among which the microsphere group has more red dots and more dead breast cancer cells.
[0084] This indicates that the microspheres obtained in Example 1 have the function of killing breast cancer cells, and the effect is better than that of doxorubicin alone.
[0085] The embodiments of the present invention have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and changes will be apparent to those skilled in the art without departing from the scope and spirit of the described embodiments.
Claims
1. A method for preparing targeted drug-loaded microspheres based on natural collagen, characterized in that: The preparation method comprises the following steps: S1: uniformly mixing polycaprolactone and a solvent to obtain an oil phase solution; uniformly mixing water and an emulsifier to obtain an aqueous phase solution; S2: mixing the aqueous phase solution and the oil phase solution and performing shear emulsification to obtain an oil-in-water emulsion; S3: stirring, centrifuging, discarding the supernatant, washing and freeze-drying the oil-in-water emulsion in sequence to obtain polycaprolactone microspheres; S4: uniformly mixing water and doxorubicin hydrochloride to obtain a doxorubicin solution; S5: mixing the polycaprolactone microspheres and the doxorubicin solution and sequentially stirring, centrifuging, discarding the supernatant, washing and freeze-drying to obtain drug-loaded polycaprolactone microspheres; S6: Under low temperature conditions, the acetic acid aqueous solution and the natural collagen are uniformly mixed and dialyzed with pure water to obtain a collagen solution; S7: Soaking the drug-loaded polycaprolactone microspheres in the collagen solution, and then sequentially centrifuging, discarding the supernatant and freeze-drying to obtain the targeted drug-loaded microspheres based on natural collagen.
2. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S1: The concentration of polycaprolactone in the oil phase solution is 5-30 mg / mL; The solvent is at least one of dichloromethane, chloroform and N,N-dimethylformamide; The concentration of the emulsifier in the aqueous phase solution is 1-7 mg / mL; The emulsifier is at least one of polyvinyl alcohol, carboxymethyl cellulose and chitosan.
3. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S2: The volume ratio of the aqueous phase solution to the oil phase solution is 3:1-9:1; The shearing speed is 5000-15000 rpm, and the shearing time is 3-12 min.
4. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S3: The stirring rate is 300-800 rpm and the time is 12-36 hours; The centrifugal speed is 8000-12000rpm and the time is 10-30min; The freeze-drying time is 24-48h.
5. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S4: the concentration of the doxorubicin solution is 2-6 mg / mL.
6. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S5: The dosage ratio of the polycaprolactone microspheres to the doxorubicin solution is 10:1-30:1 mg / mL; The stirring rate is 200-500 rpm and the time is 24-48 hours; The centrifugal speed is 8000-12000rpm and the time is 5-20min; The freeze-drying time is 24-48h.
7. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S6: The natural collagen is natural type I collagen with a complete triple helical molecular structure; The low temperature condition is a temperature less than 15°C; The concentration of the acetic acid aqueous solution is 0.1-0.5 mol / L; The concentration of the collagen solution is 0.05-0.2 mg / mL.
8. The method for preparing targeted drug-loaded microspheres based on natural collagen according to claim 1, wherein: In step S7: The soaking time is 6-10h; The centrifugal speed is 8000-12000rpm and the time is 5-15min; The freeze-drying time is 24-48h.
9. Targeted drug-loaded microspheres based on natural collagen prepared by the method for preparing targeted drug-loaded microspheres based on natural collagen according to any one of claims 1 to 8.
10. Use of the natural collagen-based targeted drug-loaded microspheres according to claim 9 in the preparation of drugs for treating breast cancer.
